Figures & data
Figure 1. Metabolic pathways involved in endogenous and exogenous ketosis. Endogenous ketosis increases lipolysis, classical hepatic ketogenesis, hyperketonemia and ketone oxidation. Exogenous ketosis with BH-BD consumption, as either a ready to drink beverage or a powder, involves intestinal hydrolysis of BH-BD, classical and non-classical hepatic ketogenesis, hyperketonemia and ketone oxidation. Abbreviations: BHB, beta-hydroxybutyrate; BH-BD, bis hexanoyl (R)-1,3-butanediol. Modifed from Crabtree et al. (Citation11) and created using BioRender.com.
![Figure 1. Metabolic pathways involved in endogenous and exogenous ketosis. Endogenous ketosis increases lipolysis, classical hepatic ketogenesis, hyperketonemia and ketone oxidation. Exogenous ketosis with BH-BD consumption, as either a ready to drink beverage or a powder, involves intestinal hydrolysis of BH-BD, classical and non-classical hepatic ketogenesis, hyperketonemia and ketone oxidation. Abbreviations: BHB, beta-hydroxybutyrate; BH-BD, bis hexanoyl (R)-1,3-butanediol. Modifed from Crabtree et al. (Citation11) and created using BioRender.com.](/cms/asset/cd254f49-a07b-4418-9548-fecacff14445/uacn_a_2117743_f0001_c.jpg)
Table 1. Nutritional information of study beverage and standard meal.
Table 2. Baseline characteristics of study participants.
Figure 3. Capillary blood BHB and glucose concentrations in healthy adults (n = 15) following consumption of 25 g or 12.5 g of BH-BD as powder, 12.5 g RTD beverage formulation, or a control drink. A: mean blood BHB concentrations over time, B: peak BHB concentration for each subject normalized to each individual’s baseline value, C: normalized BHB AUC, D: mean glucose concentrations over time, E: minimal normalized glucose concentration for each individual.
Abbreviations: AUC, area under the curve; BHB, beta hydroxybutyrate; BH-BD, bis hexanoyl (R)-1,3-butanediol; Cmax, peak concentration; Cmin, minimal concentration. Data are mean ± standard deviation. * = p <0.05 between group, ** = p <0.001, *** = p <0.0001 between group, NS = not significant; † = p <0.05 between control and POW 25 g groups.
![Figure 3. Capillary blood BHB and glucose concentrations in healthy adults (n = 15) following consumption of 25 g or 12.5 g of BH-BD as powder, 12.5 g RTD beverage formulation, or a control drink. A: mean blood BHB concentrations over time, B: peak BHB concentration for each subject normalized to each individual’s baseline value, C: normalized BHB AUC, D: mean glucose concentrations over time, E: minimal normalized glucose concentration for each individual.Abbreviations: AUC, area under the curve; BHB, beta hydroxybutyrate; BH-BD, bis hexanoyl (R)-1,3-butanediol; Cmax, peak concentration; Cmin, minimal concentration. Data are mean ± standard deviation. * = p <0.05 between group, ** = p <0.001, *** = p <0.0001 between group, NS = not significant; † = p <0.05 between control and POW 25 g groups.](/cms/asset/0cf565f2-20dc-4c42-adc7-1d604aa2f4f2/uacn_a_2117743_f0003_c.jpg)
Table 3. Post-product composite beverage tolerability score.
Data availability statement
The data presented here may be available upon reasonable request from the corresponding author and in accordance with intellectual property considerations.